The hottest worry about paperboard in the pharmace

2022-08-17
  • Detail

Concerns about paperboard in the pharmaceutical packaging market

current situation of China's pharmaceutical packaging industry

in 2003, the total output value of China's packaging industry exceeded 270 billion yuan, including 86.64 billion yuan for paper packaging, 76.42 billion yuan for plastic packaging, 20.76 billion yuan for metal packaging, 7.983 billion yuan for glass packaging, 54.23 billion yuan for packaging and printing, 15.86 billion yuan for packaging machinery, and 8.02 billion yuan for others. In 2003, the packaging industry undertook a total retail sales of 458million yuan of domestic consumer goods and a packaging package of 438.4 billion US dollars of export goods

the GDP of China's pharmaceutical packaging industry has accounted for more than 10% of the national packaging industry, which is much higher than the proportion of the entire pharmaceutical industry in the national total industrial output value

market structure

nowadays, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, with an annual growth rate of more than 10%. A survey report shows that 65% of China's pharmaceutical packaging is still behind the world average level in the 1980s. The quality of packaging materials is very low, and its contribution to the pharmaceutical industry is even weaker. In developed countries, packaging accounts for 30% of the value of drugs, while in China, this value is 10% lower

enterprise product structure

there are about 1500 enterprises, which can produce more than 50 varieties of drug packaging materials in 6 categories, with an annual output value of about 15 billion yuan, which can meet more than 80% of the needs of domestic pharmaceutical enterprises

in 1992, the State Pharmaceutical Administration implemented a license system for drug packaging material manufacturing enterprises that directly contact drugs. After two license renewals in 1995 and 1997, the enterprise structure is roughly as follows:

1. Pharmaceutical glass manufacturing enterprises: 417 (about 28%)

2. Plastic (aluminum) container manufacturers: 278 (about 18%), of which: 33 produce traditional Chinese medicine spherical shells

3. There are 165 enterprises producing sheet, film and foil (composite) materials (accounting for about 11%), including 36 enterprises producing medicinal PVC hard sheets and 35 enterprises producing PTP aluminum foil

4. Gelatin hard capsules: 116 manufacturing enterprises (about 8%), including 3 enteric coated capsules

5. 118 pharmaceutical rubber stopper manufacturers (about 8%), including 11 butyl rubber stoppers and 110 natural rubber stoppers

6. Various bottle caps: 185 (about 12%)

7. There are about 200 other manufacturers (ointment tube, desiccant, eye medicine bottle, etc.)

the production of drug outer packaging (paper products, plastic products, metal products, decorative prints) and other related products has also formed an enterprise group, which is increasingly emerging in ensuring the safety and convenience of medication and improving the commercial value of drugs

$page break $the development of pharmaceutical paperboard packaging industry is full of difficulties

paperboard packaging is mainly used for outer packaging boxes of drugs. At present, the paperboard used in drug packaging boxes mainly includes gray background white board, white background white board with recycled pulp as raw material and white board with fresh wood pulp as raw material. In terms of white cardboard, the market is mainly divided into SBS and FBB. The former uses bleached chemical pulp as raw material and has a two-layer structure, which is characterized by high whiteness, but the stiffness and thickness of the same gram weight paperboard are poor; The latter uses bleached chemical pulp as the surface and bottom layer of paperboard, while mechanical pulp as the raw material to form the middle layer, forming a three-layer structure of paperboard. Its characteristics are that under the condition of the same gram weight, it has high thickness and good hardness, which brings good die-cutting effect and crease effect. Due to the difference of paperboard structure, the gram weight of paperboard with the same thickness and stiffness will be different

first, the profit margin of pharmaceutical paperboard packaging is small

at present, the pharmaceutical industry is still in a relatively primitive state in the selection of outer packaging paperboard. When choosing medicine box materials, pharmaceutical enterprises generally choose gray bottom white board paper with recycled pulp as raw material, which is relatively cheap, as the packing material of medicine boxes for the consideration of reducing costs. In particular, over the years, most domestic drugs have been sold to patients through hospitals, and patients have almost no choice over drugs, so it doesn't matter what the drug packaging is. These low-grade gray bottom whiteboards often have fierce competition and limited profit space. As a result, the demand for white cards such as high-end products as products with high profit added value has decreased. But is it really cheap? Let's take a look at an account calculated by an expert specializing in the printing and production of cardboard medicine boxes "For the same packaging box, the average cost difference between high-grade paperboard and cheap paperboard is about 5 cents. Sometimes, due to the different printing quantity, the cost difference is oneortwo cents. However, domestic enterprises are generally unwilling to spend more money, and it is generally believed that if they can save, they will save. In fact, these enterprises have several misconceptions. For example, using high-grade paperboard to replace 300 grams of paperboard with a lower price does not need the same gram, Usually 250 grams is OK, but when domestic enterprises switch to high-grade whiteboard, they still insist on choosing 300 grams of paperboard, resulting in unnecessary waste; There are also enterprises that choose high-grade packaging cardboard only when the price of drugs is high. For low-cost drugs, of course, choose cheap paper. 2. Accuracy grade: grade 0.5 board; Some enterprises even require that the printed paperboard be covered with film because the low-cost paperboard is not crisp enough, which not only increases the cost, but also is not environmentally friendly ". The existence of these enterprises is a common misunderstanding in the whole industry, which cannot be easily changed and will take a long time

second, the demand for drug packaging is strict, which limits the use of cardboard.

with the continuous expansion of the drug market, pharmaceutical enterprises have higher and higher requirements for drug cartons. Drugs are a special commodity, and the consequences of counterfeiting and shoddy are serious. The light will affect the health of consumers, and the heavy will endanger lives. In order to effectively curb counterfeit and shoddy products and maintain the brand of enterprises, pharmaceutical enterprises have high requirements for the anti-counterfeiting of packaging paper; As a kind of commodity, the outer packaging of drugs can reflect the product grade and indirectly reflect the safety and hygiene of products. Therefore, pharmaceutical enterprises pay great attention to the decoration effect of the outer packaging of drugs, and choose cartons with high stiffness and good molding, which can improve the product grade; When consumers buy drugs of the same brand, they usually compare with the packaging of previous batches. If they find that the color of the packaging boxes of new and old batches are different, they will be suspected of counterfeit drugs, so the quality of carton materials is required to be stable; Recently, pharmaceutical enterprises have adopted advanced automatic cartoning machines, which have higher requirements on the weight and straightness of paper. These various requirements for paper will be more stringent, thus limiting the use of some paperboard

III. more than 2000 pharmaceutical enterprises are facing production stoppage, making the paperboard Market worse.

China's pharmaceutical industry GMP certification, from July 1 this year, more than 2000 pharmaceutical manufacturing enterprises that fail to pass the certification will be discontinued, accounting for 40% of the total, and the corresponding dosage of drug boxes will not be available. At the same time, paper packaging has its own shortcomings in pharmaceutical packaging - moisture resistance and protective performance are not ideal. On the other hand, cartons used for sandwich packaging are also facing fierce competition from heat shrinkable plastic packaging. Take 10 boxes or 10 bottles of sandwich packaging for example, the cost of using heat shrinkable plastic packaging is 3 to 7 cents, but carton packaging costs 50 cents to 2 yuan

facing the situation of China's accession to the WTO, foreign drugs will enter the Chinese market on a large scale, tariffs will be lowered, and the barriers of foreign drug price factors will be gradually removed. The market share of foreign medicine has increased, crowding out the domestic pharmaceutical market. The domestic pharmaceutical market will be smaller, and its packaging consumption will also be reduced, while foreign drugs are packaged and imported directly, so there is no corresponding packaging cardboard consumption in China

cardboard has a severe form in the field of pharmaceutical packaging, and its future is full of difficulties

$page break $related links world pharmaceutical packaging market

medicine is a necessity of life, and pharmaceutical packaging has always been a major part of the packaging industry. According to a survey conducted by Freedonia GROUPINC, an American industrial market research company, the demand for basic packaging of pharmaceutical products in the world will increase by 4.2% to US $11.2 billion by 2003. In terms of figures, this growth rate is slightly lower than the 4.9% during 1989-98; However, to show that we are healthier than before

among many packaging containers, the development of blister packaging is the most potential. The advantages of blister packaging are strong barrier, beautiful appearance, long shelf life, easy to use and so on. The world pharmaceutical industry advocates the use of high transparency packaging and fixed dose drugs. Blister packaging has these advantages. Perfect pharmaceutical packaging design can reduce taking errors, so the blister packaging designed with quantitative dispensing is an ideal choice

in addition, plastic bottles are still the most widely used containers, especially in Latin America, Eastern Europe and the developing Asia Pacific region, which have seen higher than the level of growth. Coupled with its high cost-effectiveness and wide range of uses (including oral liquid and other liquid drugs), its adoption will be higher. According to the survey, the coverage of pharmaceutical 1 food contact materials has increased, and the annual demand for this kind of packaging container plastic will increase by 4.4% in 2003. One reason is that the pharmaceutical industry in China, Brazil and other large developing countries is slowly developing, and for these markets, cost is still the main factor affecting the end-users' choice of packaging. In addition, with the vigorous development of proprietary drugs and special drugs in the world market, the demand for plastic bottles has also increased significantly

in terms of packaging materials, paper, which is suitable for small specimens and materials that do not produce large plastic deformation in the friction process, cardboard, plastic resin and aluminum foil are still excellent packaging materials because of their wide range of applications and good processing performance. It is predicted that paper, paperboard and plastic resin will account for 95% of the world's pharmaceutical packaging, and paper and paperboard are the most widely used materials

in addition, the survey also said that in this century, the United States, Japan, Germany, Britain, France and Italy are the world's largest pharmaceutical packaging markets. In view of the fact that multinational medical and pharmaceutical manufacturers have strengthened their investment in the Chinese medical and pharmaceutical market, China will be the fastest-growing market for the basic packaging of yunyun pharmaceutical products in the next few years

explanation of terms: GMP

GMP is the English abbreviation of the good manufacturing practice for drugs. In order to integrate with the world as soon as possible, the State Food and drug administration has formulated a timetable for the implementation of GMP in China

gmp is a scientific and advanced method for drug manufacturers to strengthen management and ensure product quality. It is an effective management method widely used in countries all over the world and an important content of international evaluation of drug quality. The main purpose of formulating and implementing GMP is to protect the interests of consumers and ensure the safe and effective use of drugs. At the same time, it is also to make drug manufacturers have laws to follow and rules to follow

the implementation of GMP certification system is a means for the state to supervise and inspect drug production enterprises, including more than 80 certification rules and more than 200 inspection items. Good hardware facilities, practical software system and high-quality personnel participation are important contents of GMP system

source: China Paper Market

Copyright © 2011 JIN SHI